{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T04:54:11Z","timestamp":1782881651974,"version":"3.54.5"},"reference-count":47,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Background: Gastric adenocarcinomas constitute a histologically and genomically heterogeneous group of cancers. The genomic classification of gastric cancers in four groups by The Cancer Genome Atlas (TCGA) has defined a framework for pathogenic discoveries. One of the groups is associated with infection by the gamma herpes virus Epstein\u2013Barr virus (EBV) and represents a distinct subset of gastric cancers with potential therapeutic opportunities. Methods: The EBV-associated cancers from the TCGA gastric cancer cohort were analyzed to determine specific mutational and mRNA expression profiles that set these cancers apart from other gastric cancer subtypes. The cBioportal for Cancer Genomics site was used for downloading and analyzing the primary data. Results: EBV-associated cancers represented about 7% of the cohort. Mutations in the catalytic alpha subunit of PI3K kinase, PIK3CA, and the epigenetic modifiers ARID1A and BCOR were common. PIK3CA mutations were observed in 80% of EBV-associated cancers and frequently affected the hotspot codons E542 and E545. The few cases without PIK3CA mutations displayed frequent alterations in ERBB2 or in the regulatory unit of PI3K. EBV-associated cancers did not display excess cytidine to thymine (C&gt;T) transitions compared with other gastric cancer genomic subtypes, as would be expected from the high genome methylation caused by the virus. In contrast, an increased rate of T to G (T&gt;G) transversions was observed in EBV-associated cancers. Translesion polymerase eta (POLH), which produces a signature characterized by a preponderance of T&gt;G, was up-regulated in EBV-associated gastric cancers and may be a contributing factor in this increase, up-regulated by wild-type p53 and over-expression of transcription factor IRF1. Conclusions: The data presented here suggest that mutagenesis in the EBV-associated gastric cancers is not a direct consequence of the virus-derived hypermethylation. Up-regulation of kinase PI3K and its pathway is a prerequisite for EBV transformation, and epigenetic alterations are frequently present, suggesting therapeutic avenues.<\/jats:p>","DOI":"10.3390\/genes17070769","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:06:34Z","timestamp":1782875194000},"page":"769","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epigenetics and DNA Base Substitutions of Epstein\u2013Barr Virus (EBV)-Related Gastric Cancers: Implications for Targeted Therapies"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9301-5951","authenticated-orcid":false,"given":"Ioannis A.","family":"Voutsadakis","sequence":"first","affiliation":[{"name":"Division of Hematology, Oncology and Blood and Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA 52240, USA"},{"name":"Section of Internal Medicine, Division of Clinical Sciences, Northern Ontario School of Medicine, Sudbury, ON P3E 2C6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","article-title":"Global burden of gastric cancer: Epidemiological trends, risk factors, screening and prevention","volume":"20","author":"Thrift","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network (2014). Comprehensive molecular characterization of gastric adenocarcinoma. Nature, 513, 202\u2013209.","DOI":"10.1038\/nature13480"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Weiss, J.G., Gallob, F., Rieder, P., and Villunger, A. (2022). Apoptosis as a Barrier against CIN and Aneuploidy. Cancers, 15.","DOI":"10.20944\/preprints202210.0341.v1"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Stanland, L.J., and Luftig, M.A. (2020). The Role of EBV-Induced Hypermethylation in Gastric Cancer Tumorigenesis. Viruses, 12.","DOI":"10.3390\/v12111222"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2217\/fvl-2018-0071","article-title":"Molecular features and translational outlook for Epstein-Barr virus-associated gastric cancer","volume":"13","author":"Stanland","year":"2018","journal-title":"Future Virol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/978-981-10-7230-7_20","article-title":"Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric Cancer","volume":"1045","author":"Fukayama","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Leong, M.M.L., and Lung, M.L. (2021). The Impact of Epstein-Barr Virus Infection on Epigenetic Regulation of Host Cell Gene Expression in Epithelial and Lymphocytic Malignancies. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.629780"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Riel, M., and Johannsen, E.C. (2025). LMP2A-The Other EBV Oncogene. Current Topics in Microbiology and Immunology, Springer.","DOI":"10.1007\/82_2025_330"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"E7257","DOI":"10.1073\/pnas.1513432112","article-title":"5-hydroxymethylation of the EBV genome regulates the latent to lytic switch","volume":"112","author":"Wille","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Kuss-Duerkop, S.K., Westrich, J.A., and Pyeon, D. (2018). DNA Tumor Virus Regulation of Host DNA Methylation and Its Implications for Immune Evasion and Oncogenesis. Viruses, 10.","DOI":"10.3390\/v10020082"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1073\/pnas.0611559104","article-title":"Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression","volume":"104","author":"Yanai","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/path.6067","article-title":"Loss of viral genome with altered immune microenvironment during tumour progression of Epstein-Barr virus-associated gastric carcinoma","volume":"260","author":"Kondo","year":"2023","journal-title":"J. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"189218","DOI":"10.1016\/j.bbcan.2024.189218","article-title":"Epstein Barr virus: A cellular hijacker in cancer","volume":"1879","author":"Alsaadawe","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/978-981-10-7230-7_17","article-title":"EBV-Encoded Latent Genes","volume":"1045","author":"Kanda","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cels.2018.03.002","article-title":"MC3 Working Group; Cancer Genome Atlas Research Network. Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines","volume":"6","author":"Ellrott","year":"2018","journal-title":"Cell Syst."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Li, B., and Dewey, C.N. (2011). RSEM: Accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform., 12.","DOI":"10.1186\/1471-2105-12-323"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Fagerberg","year":"2015","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"GTEx Consortium (2020). The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science, 369, 1318\u20131330.","DOI":"10.1126\/science.aaz1776"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00011","article-title":"OncoKB: A Precision Oncology Knowledge Base","volume":"2017","author":"Chakravarty","year":"2017","journal-title":"JCO Precis. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1158\/2159-8290.CD-23-0467","article-title":"Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer","volume":"14","author":"Suehnholz","year":"2024","journal-title":"Cancer Discov."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ng.3659","article-title":"Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium. Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance","volume":"48","author":"Secrier","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1038\/s41467-025-60836-9","article-title":"Genomic landscape of virus-associated cancers","volume":"16","author":"Nam","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-57362-1_1","article-title":"An Introduction to Virus Infections and Human Cancer","volume":"Volume 217","author":"Schiller","year":"2021","journal-title":"Viruses and Human Cancer; Recent Results in Cancer Research"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Abe, H., Kunita, A., Otake, Y., Kanda, T., Kaneda, A., Ushiku, T., and Fukayama, M. (2021). Virus-host interactions in carcinogenesis of Epstein-Barr virus-associated gastric carcinoma: Potential roles of lost ARID1A expression in its early stage. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0256440"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"215587","DOI":"10.1016\/j.canlet.2022.215587","article-title":"ARID1A loss-of-function induces CpG island methylator phenotype","volume":"532","author":"Yamada","year":"2022","journal-title":"Cancer Lett."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2217\/epi-2018-0195","article-title":"BCOR involvement in cancer","volume":"11","author":"Astolfi","year":"2019","journal-title":"Epigenomics"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"7922","DOI":"10.1073\/pnas.1303800110","article-title":"Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2","volume":"110","author":"Knutson","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nm.3799","article-title":"Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers","volume":"21","author":"Bitler","year":"2015","journal-title":"Nat. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/bloodadvances.2022007541","article-title":"Genetic and immunohistochemical profiling of NK\/T-cell lymphomas reveals prognostically relevant BCOR-MYC association","volume":"7","author":"Oishi","year":"2023","journal-title":"Blood Adv."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.molcel.2020.03.025","article-title":"MYC Controls the Epstein-Barr Virus Lytic Switch","volume":"78","author":"Guo","year":"2020","journal-title":"Mol. Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3934\/biophy.2016.1.88","article-title":"Chromatin and epigenetics: Current biophysical views","volume":"3","author":"Teif","year":"2016","journal-title":"AIMS Biophys."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1158\/0008-5472.CAN-17-3931","article-title":"DNA Polymerase Eta Prevents Tumor Cell-Cycle Arrest and Cell Death during Recovery from Replication Stress","volume":"78","author":"Barnes","year":"2018","journal-title":"Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"12622","DOI":"10.1074\/jbc.M111.313429","article-title":"Interferon regulatory factor 1 transactivates expression of human DNA polymerase \u03b7 in response to carcinogen N-methyl-N\u2019-nitro-N-nitrosoguanidine","volume":"287","author":"Qi","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/nar\/gkw1196","article-title":"Predominant role of DNA polymerase eta and p53-dependent translesion synthesis in the survival of ultraviolet-irradiated human cells","volume":"45","author":"Lerner","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10120-025-01618-6","article-title":"Predictive value of EBV-positivity in patients with gastric cancer treated with first-line nivolumab plus chemotherapy","volume":"28","author":"Kim","year":"2025","journal-title":"Gastric Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s10120-023-01445-7","article-title":"Clinical outcomes of Epstein-Barr virus (EBV)-associated metastatic and locally advanced unresectable gastric cancers (GCs) in patients receiving first-line fluoropyrimidine and platinum (FP) doublet chemotherapy","volume":"27","author":"Kim","year":"2024","journal-title":"Gastric Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","article-title":"Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer","volume":"24","author":"Kim","year":"2018","journal-title":"Nat. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1016\/j.cell.2024.04.025","article-title":"ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity","volume":"187","author":"Maxwell","year":"2024","journal-title":"Cell"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Gallimore, F., and Fandy, T.E. (2023). Therapeutic Applications of Azanucleoside Analogs as DNA Demethylating Agents. Epigenomes, 7.","DOI":"10.3390\/epigenomes7030012"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s43018-021-00249-x","article-title":"Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia","volume":"2","author":"Pappalardi","year":"2021","journal-title":"Nat. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1158\/1078-0432.CCR-16-1896","article-title":"Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response","volume":"23","author":"Schneider","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.5213\/inj.1632740.370","article-title":"Targeting the Phosphatidylinositol-3-kinase Pathway in Gastric Cancer: Can Omics Improve Outcomes?","volume":"20","author":"Tran","year":"2016","journal-title":"Int. Neurourol. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1158\/1541-7786.MCR-23-0034","article-title":"CBF-Beta Mitigates PI3K-Alpha-Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric Cancer","volume":"21","author":"Stanland","year":"2023","journal-title":"Mol. Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Voutsadakis, I.A. (2021). PI3KCA Mutations in Uterine Cervix Carcinoma. J. Clin. Med., 10.","DOI":"10.3390\/jcm10020220"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/7\/769\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:50:15Z","timestamp":1782877815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/7\/769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":47,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["genes17070769"],"URL":"https:\/\/doi.org\/10.3390\/genes17070769","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]}}}